Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Cancer Immunol Res. 2017 Nov 6;5(12):1152–1161. doi: 10.1158/2326-6066.CIR-17-0189

Fig 3. Histology and IHC of tumor tissue pre and post intratumoral injection of mRNA c-Met-CAR T cells from one treated patient.

Fig 3

Histologic (H&E) and IHC evaluation of c-Met expression and T cell (CD3+, CD4+, CD8+) and macrophage (CD68+) infiltration in tumor tissues of pre-treatment, away from intratumoral injection site and at intratumoral injection site from a patient treated with 3 × 108 mRNA c-Met-CAR T cells.